# Effect of Increlex® on Children With Crohn Disease

> **NCT00764699** · PHASE2,PHASE3 · TERMINATED · sponsor: **Nationwide Children's Hospital** · enrollment: 3 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** rhIGF (Increlex)

## Key facts

- **NCT ID:** NCT00764699
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** PI left institution
- **Last updated:** 2018-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00764699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00764699, "Effect of Increlex® on Children With Crohn Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00764699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*